Related Experiment Video
Updated: Jul 7, 2026
08:12
Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
The experience with the Epiclose-T vascular access closure device: a human study
Hürkan Kurşaklioğlu1, Atila Iyisoy, Cem Barçin
1Department of Cardiology, Gülhane Military Medical Academy, Ankara, Turkey.
Summary
The Epiclose-T device safely and effectively achieves arterial hemostasis after cardiac catheterization, with high patient satisfaction and no significant complications compared to manual compression.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Medical Devices
Background:
- Arterial access site closure is crucial after cardiac catheterization.
- The Epiclose-T is a novel double-balloon device designed for direct pressure on arteriotomy sites.
- It aims to facilitate natural coagulation without leaving foreign material.
Purpose of the Study:
- To prospectively assess the initial safety and efficacy of the Epiclose-T closure device.
- To evaluate patient comfort and satisfaction with the Epiclose-T device.
- To compare Epiclose-T with manual compression for arterial access site hemostasis.
Main Methods:
- A prospective, randomized, controlled study was conducted.
- The study group (32 patients) used the Epiclose-T device.
- The control group (39 patients) received manual compression.
Main Results:
- Hemostasis was achieved in 90.6% of patients using Epiclose-T.
- No statistically significant differences in major or minor complications were observed between groups.
- Major complications like large hematoma and pseudoaneurysm were more frequent in the manual compression group.
Conclusions:
- Epiclose-T provides an easy, safe, and effective method for achieving hemostasis.
- The device demonstrates no significant minor or major complications.
- Patients reported high satisfaction with the Epiclose-T closure device.
